Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-833,000
Closed -$12.2M 621
2025
Q3
$12.2M Sell
833,000
-50,000
-6% -$510K 0.12% 168
2025
Q2
$8.68M Hold
883,000
0.07% 216
2025
Q1
$6.5M Buy
883,000
+120,000
+16% +$1.05M 0.08% 200
2024
Q4
$5.95M Hold
763,000
0.07% 221
2024
Q3
$5.63M Buy
763,000
+40,000
+6% +$336K 0.07% 234
2024
Q2
$5.74M Buy
723,000
+50,000
+7% +$446K 0.08% 207
2024
Q1
$7.8M Buy
673,000
+170,000
+34% +$1.88M 0.11% 185
2023
Q4
$5.64M Buy
503,000
+450,000
+849% +$4.14M 0.08% 202
2023
Q3
$818K Buy
+53,000
New +$890K 0.01% 365

Other funds holding ETNB

Erste Asset Management's ETNB Position: Q4 2025 in Review

Erste Asset Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 833,000 shares — an estimated $12.2M sold.

Erste Asset Management first reported a position in ETNB in Q3 2023 and held it in 9 quarters. The position peaked at $12.2M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Erste Asset Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Erste Asset Management sold 833,000 89bio shares in Q4 2025, an estimated $12.2M.
  • Erste Asset Management first reported a position in 89bio in Q3 2023 and held it in 9 quarters.
  • Erste Asset Management's 89bio position peaked at $12.2M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Erste Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.